New Potomac Partners, LLC Charles River Laboratories International, Inc. Transaction History
New Potomac Partners, LLC
- $192 Million
- Q3 2024
A detailed history of New Potomac Partners, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, New Potomac Partners, LLC holds 300 shares of CRL stock, worth $55,995. This represents 0.03% of its overall portfolio holdings.
Number of Shares
300Holding current value
$55,995% of portfolio
0.03%Shares
7 transactions
Others Institutions Holding CRL
# of Institutions
695Shares Held
52.2MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.14 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$950 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$698 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$398 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$362 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.49B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...